FROM BIO CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,140 KRW | -0.23% |
|
+0.23% | -30.29% |
| 2023 | From Bio Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2021 | From Bio Co.,Ltd has completed an IPO in the amount of KRW 43.2 billion. | CI |
| Sales 2022 | 99.33B 72.21M | Sales 2023 | 66.72B 48.51M | Capitalization | 86.91B 63.18M |
|---|---|---|---|---|---|
| Net income 2022 | 3.24B 2.36M | Net income 2023 | -11.08B -8.05M | EV / Sales 2022 | 0.93 x |
| Net cash position 2022 | 26.32B 19.14M | Net Debt 2023 | 12.32B 8.96M | EV / Sales 2023 | 1.49 x |
| P/E ratio 2022 |
36.6
x | P/E ratio 2023 |
-7.85
x | Employees | 128 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.03% |
More Fundamentals
* Assessed data
| 1 day | -0.23% | ||
| 1 week | +0.23% | ||
| Current month | -17.85% | ||
| 1 month | -21.47% | ||
| 3 months | -27.21% | ||
| 6 months | -33.33% | ||
| Current year | -30.29% |
1 week
2 110.00
2 240.00
1 month
2 090.002 880.00
Current year
2 090.003 580.00
1 year
2 090.004 585.00
3 years
2 090.0012 125.00
5 years
2 090.0012 125.00
10 years
2 090.0012 125.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tae-Jin Sim
CEO | Chief Executive Officer | 51 | - |
Jun-Ho Lee
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Ji-Hoon Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tae-Jin Sim
CEO | Chief Executive Officer | 51 | - |
Ji-Hoon Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Seung-Ho Lee
BRD | Director/Board Member | 48 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 2,140 | -0.23% | 84,929 |
| 24-04-25 | 2,145 | -0.46% | 74,271 |
| 24-04-24 | 2,155 | +0.23% | 107,560 |
| 24-04-23 | 2,150 | -0.23% | 192,394 |
| 24-04-22 | 2,155 | +0.94% | 108,534 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
From Bio Co Ltd is a Korea-based company principally engaged in the health functional food business. The Company is engaged in the production and sale of functional foods related to joint health, stomach health, eye health, and sleep health and others. In addition, the Company is engaged in the manufacture and sale of wild mango and other diet food, creams, shampoos, soaps and other products.
Sector
Food Processing
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -30.29% | 44.01M | |
| +8.20% | 7.78B | |
| +0.34% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
- Stock Market
- Equities
- A377220 Stock
